Strasbourg, 10th July 2017:
Targeted at persons suffering from diabetes (Type 1 diabetics and some Type 2 diabetics) needing to administer insulin, this innovative medical device is being designed to offer patients a better means to manage the disease, and thus a better quality of life. For more info about the new insulin delivery device under development by Defymed, please check the related Press Release or the ExOlin ® website page.